CapsoVision, a medical device developer, submitted an application Nov. 6 to the FDA requesting breakthrough device designation for its CapsoCam UGI capsule, aimed at detecting early-stage pancreatic ...

CapsoVision (CV) announced that it has submitted an application to the FDA on November 6, requesting breakthrough device designation to accelerate ...

Non-invasive capsule endoscopy system aims to enable earlier detection of pancreatic ductal adenocarcinoma - among the most fatal cancers worldwideSARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- ...

After pH testing of either type, abnormal acid exposure time (AET) when the pH in the lower esophagus is greater than 6% ...

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique ...

People in York are joining a clinical trial where a simple test could help transform cancer screening and save lives.

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

Gastrointestinal distress should not be ignored. When identified and managed early, they can make all the difference in ...